Cellecta

Cellecta is a functional genomics company offering a diversified portfolio of products and services centered on pooled genetic screening, cell lineage tracking, and immune repertoire profiling. Founded in 2006 and headquartered in Mountain View, California, the company operates as a private, revenue-generating platform and services provider, supporting the drug discovery pipeline from target ID through biomarker analysis. Its core value proposition lies in integrating high-quality lentiviral constructs, custom library generation, and sophisticated NGS-based analysis into a single provider ecosystem, reducing complexity for research and development teams.

Integrated suite for functional genomics including pooled CRISPR/RNAi screening libraries, CloneTracker cell barcoding, DriverMap immune receptor & targeted RNA-seq profiling, lentiviral vector systems, and bioinformatics services.

Cellecta competes in a crowded market against major public tools companies (e.g., Thermo Fisher, Revvity) and specialized startups. Its differentiation lies in its integrated offering of high-quality lentiviral libraries, cell barcoding, immune profiling, and supporting services, positioning it as a specialized, full-service provider rather than a vendor of individual components.